A detailed history of Aton Ra Partners transactions in Guardant Health, Inc. stock. As of the latest transaction made, Aton Ra Partners holds 9,348 shares of GH stock, worth $286,796. This represents 0.5% of its overall portfolio holdings.

Number of Shares
9,348
Previous 9,756 4.18%
Holding current value
$286,796
Previous $289,000 12.8%
% of portfolio
0.5%
Previous 0.61%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$21.58 - $29.5 $8,804 - $12,036
-408 Reduced 4.18%
9,348 $252,000
Q3 2023

Oct 25, 2023

SELL
$25.8 - $39.97 $19,221 - $29,777
-745 Reduced 7.09%
9,756 $289,000
Q2 2023

Jul 18, 2023

SELL
$20.94 - $38.01 $29,295 - $53,175
-1,399 Reduced 11.76%
10,501 $375,000
Q1 2023

May 05, 2023

SELL
$22.92 - $33.76 $38,345 - $56,480
-1,673 Reduced 12.33%
11,900 $278,000
Q4 2022

Feb 02, 2023

SELL
$25.44 - $59.78 $131,702 - $309,481
-5,177 Reduced 27.61%
13,573 $369,000
Q3 2022

Nov 14, 2022

SELL
$43.66 - $61.0 $76,841 - $107,360
-1,760 Reduced 8.58%
18,750 $1.01 Million
Q2 2022

Aug 15, 2022

SELL
$28.82 - $77.35 $659,689 - $1.77 Million
-22,890 Reduced 52.74%
20,510 $827,000
Q1 2022

May 16, 2022

SELL
$48.25 - $100.49 $519,314 - $1.08 Million
-10,763 Reduced 19.87%
43,400 $2.88 Million
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $791,825 - $1.07 Million
8,926 Added 19.73%
54,163 $5.42 Million
Q3 2021

Nov 15, 2021

BUY
$98.77 - $132.17 $454,440 - $608,114
4,601 Added 11.32%
45,237 $5.66 Million
Q2 2021

Aug 12, 2021

SELL
$109.77 - $165.68 $2.43 Million - $3.67 Million
-22,142 Reduced 35.27%
40,636 $5.05 Million
Q1 2021

May 17, 2021

BUY
$127.04 - $179.1 $644,600 - $908,753
5,074 Added 8.79%
62,778 $9.58 Million
Q4 2020

Feb 19, 2021

BUY
$99.96 - $135.93 $5.77 Million - $7.84 Million
57,704 New
57,704 $7.44 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.14B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Aton Ra Partners Portfolio

Follow Aton Ra Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.